APA Цитирование

Ying, X., Tu, J., Wang, W., Li, X., Xu, C., & Ji, J. (2019). FGFR2-BICC1: A Subtype Of FGFR2 Oncogenic Fusion Variant In Cholangiocarcinoma And The Response To Sorafenib. Onco Targets Ther.

Chicago-стиль цитирования

Ying, Xihui, Jianfei Tu, Wenxian Wang, Xingliang Li, Chunwei Xu, and Jiansong Ji. "FGFR2-BICC1: A Subtype Of FGFR2 Oncogenic Fusion Variant In Cholangiocarcinoma And The Response To Sorafenib." Onco Targets Ther 2019.

MLA-цитирование

Ying, Xihui, et al. "FGFR2-BICC1: A Subtype Of FGFR2 Oncogenic Fusion Variant In Cholangiocarcinoma And The Response To Sorafenib." Onco Targets Ther 2019.

Предупреждение: эти цитированмия не могут быть всегда правильны на 100%.